IC‐P‐027: New metabolic understanding into innovative strategies for early diagnostics and therapy of Alzheimer's disease

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Alzheimer's & Dementia

• Publication date

  2009-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.jalz.2009.05.047
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• ‘Machine Learning’ multiclassification for stage diagnosis of Alzheimer’s disease utilizing augmented blood gene expression and feature fusion

  2025cites this paper
• Early Dysregulation of RNA Splicing and Translation Processes Are Key Markers from Mild Cognitive Impairment to Alzheimer’s Disease: An In Silico Transcriptomic Analysis

  2025cites this paper
• Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems

  2024cites this paper
• Multistage Diagnosis of Alzheimer’s Disease from Clinical Data Using ‘Deep Ensemble Learning’

  2024cites this paper
• Akkermansia muciniphila improve cognitive dysfunction by regulating BDNF and serotonin pathway in gut-liver-brain axis

  2024cites this paper
• Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease

  2024cites this paper
• Neurodegenerative effects of air pollutant Particles: Biological mechanisms implicated for Early-Onset Alzheimer's disease.

  2024cites this paper
• Circadian rhythm of brain‐derived neurotrophic factor in serum and plasma

  2024cites this paper
• Association between salivary mature brain‐derived neurotrophic factor and psychological distress in healthcare workers

  2023cites this paper
• Dentate Gyrus Granule Cells Show Stability of BDNF Protein Expression in Mossy Fiber Axons with Age, and Resistance to Alzheimer’s Disease Neuropathology in a Mouse Model

  2023cites this paper
• The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer’s disease: a new perspective

  2023influential citation
• Entropy and Fractal Analysis of EEG Signals for Early Detection of Alzheimer's Dementia

  2023cites this paper
• Stability of dentate gyrus granule cell mossy fiber BDNF protein expression with age and resistance of granule cells to Alzheimer’s disease neuropathology in a mouse model

  2023cites this paper
• Difference in Methylation and Expression of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Mild Cognitive Impairment

  2023cites this paper
• BDNF and Pro-BDNF in Amyotrophic Lateral Sclerosis: A New Perspective for Biomarkers of Neurodegeneration

  2022cites this paper
• Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential

  2022cites this paper
• Gut microbiota in dementia with Lewy bodies

  2022cites this paper
• Association of plasma BDNF levels with different stages of Alzheimer’s disease: a cross-sectional study

  2022cites this paper
• Gene- and Gender-Related Decrease in Serum BDNF Levels in Alzheimer’s Disease

  2022cites this paper
• Tensor-Based Multi-Modality Feature Selection and Regression for Alzheimer's Disease Diagnosis

  2022cites this paper
• Alzheimer’s Disease Diagnosis and Biomarker Analysis Using Resting-State Functional MRI Functional Brain Network With Multi-Measures Features and Hippocampal Subfield and Amygdala Volume of Structural MRI

  2022cites this paper
• Assessing the Value of Therapies in Alzheimer’s Disease

  2021influential citation
• Perilla Seed Oil Enhances Cognitive Function and Mental Health in Healthy Elderly Japanese Individuals by Enhancing the Biological Antioxidant Potential

  2021cites this paper
• The improvement of cognitive deficits after whole-body crryotherapy - A randomised controlled trial.

  2021cites this paper
• No association of both serum pro‐brain‐derived neurotrophic factor (proBDNF) and BDNF concentrations with depressive state in community‐dwelling elderly people

  2021cites this paper
• Differential Associations Between BDNF and Memory Across Older Black and White Adults With HIV Disease

  2021cites this paper
• Increased plasma brain-derived neurotrophic factor (BDNF) as a potential biomarker for and compensatory mechanism in mild cognitive impairment: a case-control study

  2021influential citation
• Investigation of the Molecular Role of Brain-Derived Neurotrophic Factor in Alzheimer’s Disease

  2021cites this paper
• A comprehensive program of cognitive stimulation with digital inclusion, physical activity and social interaction can modify BDNF levels and improve cognition in adults over 50: a randomized controlled pilot study

  2021cites this paper
• Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event‐based model of disease progression

  2020cites this paper
• Modeling the behavior of persons with mild cognitive impairment or Alzheimer’s for intelligent environment simulation

  2020cites this paper
• A narrative review of brain-derived neurotrophic factor (BDNF) on cognitive performance in Alzheimer’s disease

  2020cites this paper
• Classifying Early and Late Mild Cognitive Impairment Stages of Alzheimer’s Disease by Analyzing Different Brain Areas

  2020cites this paper
• Tau-Mediated Dysregulation of Neuroplasticity and Glial Plasticity

  2020cites this paper
• MiR-9-5p inhibits mitochondrial damage and oxidative stress in AD cell models by targeting GSK-3β

  2020cites this paper
• Stroke and Alzheimer’s Disease: A Mendelian Randomization Study

  2020cites this paper
• A Comprehensive Machine-Learning Model Applied to Magnetic Resonance Imaging (MRI) to Predict Alzheimer’s Disease (AD) in Older Subjects

  2020cites this paper
• The effects of PPAR-γ agonist pioglitazone on hippocampal cytokines, brain-derived neurotrophic factor, memory impairment, and oxidative stress status in lipopolysaccharide-treated rats

  2019cites this paper
• CYTOKINES AND BRAIN-DERIVED NEUROTROPHIC FACTOR IN CONTEXT OF COGNITIVE IMPAIRMENT IN THE ELDERLY

  2019cites this paper
• A cross-sectional study of serum Brain Derived Neurotropic Factor (BDNF) concentrations in a Saudi population and changes associated with the use of Selective Serotonin Reuptake Inhibitors (SSRIs) in patients with Alzheimer's disease

  2018influential citation
• Effects of physical activity on delayed memory measures in randomized controlled trials with nonclinical older, mild cognitive impairment, and dementia participants

  2018cites this paper
• Postmortem Brain, Cerebrospinal Fluid, and Blood Neurotrophic Factor Levels in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

  2018cites this paper
• Reduced Serum Levels of Brain-Derived Neurotrophic Factor Are Related to Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus

  2018cites this paper
• Differential Peripheral Inflammatory Factors Associated with Cognitive Function in Patients with Heart Failure

  2018cites this paper
• Reducing the Levels of Akt Activation by PDK1 Knock-in Mutation Protects Neuronal Cultures against Synthetic Amyloid-Beta Peptides

  2018cites this paper
• Peripheral Blood Brain-Derived Neurotrophic Factor as a Biomarker of Alzheimer’s Disease: Are There Methodological Biases?

  2018influential citation
• BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF

  2017cites this paper
• Decreased peripheral brain-derived neurotrophic factor levels in Alzheimer’s disease: a meta-analysis study (N=7277)

  2017cites this paper
• Minocycline reduces inflammatory parameters in the brain structures and serum and reverses memory impairment caused by the administration of amyloid &bgr; (1–42) in mice

  2017cites this paper
• Effects of Ginsenoside Rg1 on Learning and Memory in a Reward‐directed Instrumental Conditioning Task in Chronic Restraint Stressed Rats

  2017cites this paper
• Exploring Serum Levels of Brain Derived Neurotrophic Factor and Nerve Growth Factor Across Glaucoma Stages

  2017cites this paper
• The role of BDNF in Alzheimer's disease.

  2017cites this paper
• Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy

  2017cites this paper
• Characterizing the Developmental and Reproductive Toxicities of Cannabidiol and Δ9-Tetrahydrocannabinol

  2017cites this paper
• Exercise-induced neuroprotective effects on neurodegenerative diseases: the key role of trophic factors

  2016cites this paper
• BDNF Serum Levels in Alzheimer’s Disease and Mild Cognitive Impairment

  2016cites this paper
• Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer’s Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis

  2016influential citation
• Brain-Derived Neurotrophic Factor Serum Levels and Hippocampal Volume in Mild Cognitive Impairment and Dementia due to Alzheimer Disease

  2016cites this paper
• BDNF Responses in Healthy Older Persons to 35 Minutes of Physical Exercise, Cognitive Training, and Mindfulness: Associations with Working Memory Function

  2016cites this paper
• A comparison of neurodegeneration linked with neuroinflammation in different brain areas of rats after intracerebroventricular colchicine injection

  2016cites this paper
• The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease.

  2015cites this paper
• Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects

  2015cites this paper
• Brain amyloidosis ascertainment from cognitive, imaging, and peripheral blood protein measures

  2015cites this paper
• Brain-Derived Neurotrophic Factor in Alzheimer’s Disease: Risk, Mechanisms, and Therapy

  2015influential citation
• Brain-derived Neurotrophic Factor Is Associated with Cognitive Impairment in Elderly Korean Individuals

  2015cites this paper
• Lack of an association of BDNF Val66Met polymorphism and plasma BDNF with hippocampal volume and memory

  2015cites this paper
• Development of mature BDNF‐specific sandwich ELISA

  2015cites this paper
• THE OPPORTUNITY OF BRAIN NEUROTROPHIC FACTOR USE AS A MARKER OF EFFECTIVE TREATMENT IN DEGENERATIVE, TRAUMATIC AND ISCHEMIC DAMAGE OF BRAIN Roslavtseva V.V.1, Salmina A.B.1, Prokopenko S.V.1, Kobanenko I.V.2, Rezvitskaya G.G.2

  2015cites this paper
• Differences in BDNF Serum Levels in Patients with Alzheimer’s Disease and Mild Cognitive Impairment

  2015cites this paper
• Lower Cerebrospinal Fluid Concentration of Brain-Derived Neurotrophic Factor Predicts Progression from Mild Cognitive Impairment to Alzheimer’s Disease

  2015cites this paper
• Sporadic Alzheimer's disease fibroblasts display an oxidative stress phenotype

  2015cites this paper
• Beyond the Hypothesis of Serum Anticholinergic Activity in Alzheimer's Disease: Acetylcholine Neuronal Activity Modulates Brain-Derived Neurotrophic Factor Production and Inflammation in the Brain

  2015cites this paper
• Serum brain‐derived neurotrophic factor levels in epilepsy

  2014cites this paper
• Associations Between ApoEε4 Carrier Status and Serum BDNF Levels—New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer’s Disease

  2014cites this paper
• A Large, Cross-Sectional Observational Study of Serum BDNF, Cognitive Function, and Mild Cognitive Impairment in the Elderly

  2014cites this paper
• GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression.

  2014cites this paper
• Biomarkers for Preclinical Alzheimer's Disease

  2014cites this paper
• Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

  2014cites this paper
• Effect of Cognitive Training on the Expression of Brain-Derived Neurotrophic Factor in Lymphocytes of Mild Cognitive Impairment Patients

  2014cites this paper
• Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease.

  2014cites this paper
• Apathy and APOE4 are associated with Reduced BDNF Levels in Alzheimer's Disease

  2014cites this paper
• Plasma BDNF levels are correlated with aggressiveness in patients with amnestic mild cognitive impairment or Alzheimer disease

  2014influential citation
• Is Altered BDNF Biosynthesis a General Feature in Patients with Cognitive Dysfunctions?

  2013cites this paper
• NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection?

  2013cites this paper
• Neuroinflammation and Brain Functional Disconnection in Alzheimer’s Disease

  2013cites this paper
• NGF and BDNF long-term variations in the thyroid, testis and adrenal glands of a mouse model of fetal alcohol spectrum disorders.

  2013cites this paper
• Val66Met polymorphism and BDNF levels in Alzheimer's disease patients in North Indian population

  2013cites this paper
• Molecular Mechanisms of Environmental Enrichment: Impairments in Akt/GSK3β, Neurotrophin-3 and CREB Signaling

  2013cites this paper
• Cognitive and behavioural effects of physical exercise in psychiatric patients.

  2012cites this paper
• Modulation of Alzheimer's Disease Pathology and Neuroplasticity by Environmental Factors

  2012cites this paper
• An enriched environment improves cognitive performance in mice from the senescence-accelerated prone mouse 8 strain

  2012cites this paper
• Robust changes in expression of brain-derived neurotrophic factor (BDNF) mRNA and protein across the brain do not translate to detectable changes in BDNF levels in CSF or plasma

  2012cites this paper
• BDNF serum concentrations show no relationship with diagnostic group or medication status in neurodegenerative disease.

  2012cites this paper
• Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients.

  2011influential citation
• Therapeutic Efficacy of Intranasally Delivered Mesenchymal Stem Cells in a Rat Model of Parkinson Disease

  2011cites this paper
• Physical exercise alleviates debilities of normal aging and Alzheimer’s disease

  2011cites this paper
• Infarctus cérébral et plasticité : focus sur le BDNF

  2011cites this paper
• Neuroprotective Effect of Neuropeptide Y against Beta-Amyloid 25–35 Toxicity in SH-SY5Y Neuroblastoma Cells Is Associated with Increased Neurotrophin Production

  2011cites this paper
• BDNF-trkB signaling in late life cognitive decline and Alzheimer’s disease

  2011cites this paper
• Depression and Brain-derived Neurotrophic Factor Levels in Alzheimer's Disease

  2011cites this paper